One study reported that NRXN2 negatively regulated the activity of nuclear factor erythroid 2-related factor 2 (NRF2) and participates in the emergence and progression of multiple diseases, like carcinoma, metabolism, and neurodegenerative diseases [8]. Here, NFE2L2 is linked to carcinoma.